Citigroup Lowers ImClone to Hold

Analyst Yaron Werber says the drugmaker's royalty obligations are higher than the Street's expectations

Citigroup downgraded ImClone Systems (IMCL ) to hold from buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.